ArticleNature communications2017

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.

Vural Tagal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.